Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD216—325m (Dealroom.co estimates Jan 2010.)
Cambridge Massachusetts (HQ)
Authorizing premium user...